<em>BRAF</em> Mutation Status in Circulating Tumor DNA from Patients with Metastatic Colorectal Cancer: Extended Mutation Analysis from the AGEO RASANC Study

<em>BRAF</em> Mutation Status in Circulating Tumor DNA from Patients with Metastatic Colorectal Cancer: Extended Mutation Analysis from the AGEO RASANC Study

In patients with metastatic colorectal cancer (mCRC), <i>RAS</i> and <i>BRAF</i> mutations are currently determined by tumor sample analysis. Here, we report <i>BRAF</i> mutation status analysis in paired tumor tissue and plasma samples of mCRC patients included i...

Full description

Bibliographic Details
Main Authors: Leo Mas, Jean-Baptiste Bachet, Valerie Taly, Olivier Bouché, Julien Taieb, Romain Cohen, Aurelia Meurisse, Corinne Normand, Jean-Marc Gornet, Pascal Artru, Samy Louafi, Anne Thirot-Bidault, Isabelle Baumgaertner, Romain Coriat, David Tougeron, Thierry Lecomte, Florence Mary, Thomas Aparicio, Lysiane Marthey, Helene Blons, Dewi Vernerey, Pierre Laurent-Puig
Format: Article
Language:English
Published: MDPI AG 2019-07-01
Series:Cancers
Subjects:
colorectal cancer
circulating tumor DNA
accuracy
liver metastases
NGS
methylated biomarker
Online Access:https://www.mdpi.com/2072-6694/11/7/998

Internet

https://www.mdpi.com/2072-6694/11/7/998

Similar Items